Neutral
What Guardant Health (GH)'s New HER2-Positive NSCLC Companion Dx Approval Means For Shareholders
Guardant Health (GH) recently received FDA approval for its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s HERNEXE...